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This special edition of Health Psychology Review provides a very impressive and welcome 
attempt to synthesise the evidence to date on the effectiveness of self-regulation strategies in 
understanding and predicting health behaviour change. In this brief commentary I reflect on 
three issues: (a) the importance of small treatment effects; (b) variability in how interventions 
are delivered; and (c) the importance of emotion in relation to self-regulation. 
 
Is small bad? 
This special issue clearly demonstrates that there are significant improvements that need to be 
made in systematic reviews in this field, e.g., reporting a protocol, using an established 
classification system, using GRADE, assessing risk of bias, publication bias, etc. (Hennessy, 
Johnson, Acabchuk, McCloskey & Stewart-James, 2019). When the current evidence is 
systematically appraised, those interventions that are successful often appear to produce quite 
small effect sizes (Hennessy et al. 2019). Health Psychologists often appear almost 
apologetic in the tone of reporting small effects. However, as I have argued before 
(O’Carroll, 2013), as a discipline, perhaps we should be more positive about the fact that we 
can bring about important, if modest, behaviour change as a result of our interventions. 
Further, from the reviews in the special issue, some self-regulatory behaviour change 
techniques appear to be effective across interventions, e.g. goal- setting, self-monitoring and 
personalised feedback (Hennessey et al. 2019).  
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A comparison with the reporting of treatment effects from medicine is worthy of 
consideration. For example, “Medicine A can bring about a 20% risk reduction for 
myocardial infarction (MI)”. This impressive sort of claim is often presented as a relative risk 
reduction rather than an absolute risk reduction - the latter is always lower. For example, in 
the long-term, statins reduce cardiovascular events from 18% to 14% (primary and secondary 
prevention combined), an absolute risk reduction of 4% but a relative risk reduction of 21% 
(Leucht, Hierl, Kissling, Dold, & Davis 2012). If you are “selling” your treatment effect, 
21% is obviously much more impressive than 4%! In medicine, the absolute risk reductions 
are often quite small, and the general public may well believe that the medications they have 
been prescribed are much more effective than they actually are. Trewby et al. (2002) studied 
the threshold of benefit for a hypothetical cholesterol-lowering drug and found that three-
quarters of patients would not take a drug offering 5% or less absolute risk reduction over 5 
years. Five percent is roughly the efficacy of best medical treatment. The general public’s 
expectation of benefit from a preventive drug may thus be significantly higher than the actual 
benefit provided by current drug treatments. Turning to our own discipline, at a population 
level, how important are small treatment effects? A recent example from Steptoe (2019) is 
illuminating. He reports that psychologists may be disappointed if their interventions lead to 
a 2-3% change in the outcome. But a small percentage point change in thousands of people 
could be of vital benefit at the population level. In a country the size of the UK, every 2-
percentage point fall in tobacco smoking prevalence results in more than 8,000 deaths averted 
per year (Steptoe, 2019 p.586). Few resources are available for psychological researchers that 
explain how they can quantify which effect sizes are practically meaningful, and which are 
not. Anvari and Lakens (2019) provide a helpful guide on this topic. 
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Another way of presenting treatment efficacy is by using the number needed to treat (NNT).  
This issue is well reviewed by Ogden (2016) in her consideration of cost-benefit analyses. 
The NNT indicates how many people need to take any given treatment to prevent one event 
(i.e. an MI). For example, an NNT of 1 indicates that all patients benefit, whereas an NNT of 
2 indicates that only 50% of patients benefit. As in the discussion of relative and absolute risk 
reduction above, I suspect that many members of the general public would be very surprised 
at the effectiveness of common medical treatments if they were presented as NNTs. Let us 
look at a couple of examples taken from the NNT website (https://www.thennt.com/). This is 
a website established by a group of physicians who have developed a framework and rating 
system to evaluate therapies based on their patient-important benefits and harms. The authors 
use high quality, evidence-based studies (frequently, but not always Cochrane Reviews) to 
calculate the NNTs for a variety of common medical treatments. 
The first of two examples (taken from https://www.thennt.com/) is an examination of the 
effectiveness of taking aspirin to prevent cardiovascular disease in patients with known heart 
disease or previous stroke. The NNT to prevent death is 1 in 333, i.e. 333 people are 
prescribed aspirin to prevent 1 death. We also need to consider the potential for all treatments 
(including psychological interventions) to cause harm. In the above case, 1 in 400 were 
harmed (a major bleeding event). A second example considered aspirin to prevent a first heart 
attack or stroke. In this case, 1 in 1667 had a cardiovascular problem prevented and 1 in 3333 
were harmed (major bleeding event). Are most patients taking this treatment really aware of 
the true likelihood of benefit and harm? But what about the relative effectiveness of well-
established psychological interventions? Psychotherapy is recognised as effective treatment 
for depression and anxiety. A meta-analysis of the effectiveness of psychotherapy treatment 
studies for depression in adults concluded that, in the highest quality studies, the standardised 
mean treatment effect was a modest d = 0.22 and the NNT was 8 (Cuijpers, van Straten, 
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Bohlmeijer, Hollon, & Andersson, 2009). If a person is offered a course of psychological 
treatment for depression, and they ask how likely it is to be effective, should we say that 
“there is a 1 in 8 chance you will benefit”? How is this likely to impact on the person’s 
likelihood of engaging with an evidence-based psychological treatment that is widely 
recommended internationally (particularly if the depressed person has the common 
depressive negative triad of a negative outlook on themselves, their environment and their 
future)? Are optimism and positive expectation not important determinants of all treatment 
outcomes? It is very clear from research on the placebo effect that positive expectations are a 
crucial part of treatment efficacy (Rief & Petrie, 2016). How should we best communicate 
modest treatment effectiveness evidence in both medicine and psychology? How should we 
help people make truly informed decisions about such interventions? These are important and 
challenging issues. My impression is that Health Psychologists are much more likely to 
present their intervention efficacy findings cautiously, however, we need to be fully aware of 
the implications of such caution and the wider comparative presentation of treatment efficacy 
in psychology and medicine. 
“It ain’t what you do it’s the way that you do it, and that’s what gets results” 
With due acknowledgement to Ella Fitzgerald and later, Fun Boy Three with Bananarama, 
the title of this song is important in relation to Health Psychology interventions. 
When we review the effectiveness of interventions, it is vital that the reporting of the 
methods allows us to ascertain exactly what was done, by whom and how it was conducted.  
There is now a wealth of literature documenting that, in the past, this has rarely been reported 
in sufficient detail to allow for replication. By way of example, Hennessey et al. (2019) 
report that the content of “stress management” interventions is likely to be highly variable 
across studies which then creates significant problems when attempting to synthesise findings 
(mixing apples with oranges?). On the plus side, this situation is improving, and 
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advancements in taxonomies of behaviour change and tighter operational definitions of 
specific behaviour change techniques (BCTs) make it likely that going forward, replication of 
interventions should be made easier and allow us to better integrate and evaluate intervention 
effectiveness. However, how interventions are delivered, and variability in this form of 
delivery must also be critical determinants of intervention effectiveness. 
Dombrowski, O'Carroll, & Williams (2016) propose that behaviour change interventions 
consist of three broad groups of interconnected components: (1) BCTs (i.e., the content of the 
intervention); (2) theory (i.e., the processes through which the intervention is believed to 
influence behaviour); and (3) the Form of Delivery (FoD) (i.e., the way in which the 
intervention is delivered).  Dombrowski et al. (2016) define FoD as including all features 
through which behaviour change intervention content is conveyed including the provider, 
format, materials, setting, intensity, tailoring, and style.  We need to study variability in FoD 
and how it affects outcomes in self-regulation interventions e.g. mode of delivery (face-to-
face, telephone, email, text, app) and time dynamics – the when, frequency and duration of 
intervention delivery. 
We can also learn from research evidence in Clinical Psychology where marked variation in 
therapy effectiveness has been explained by therapist variables, as well as the specific 
intervention content. For example, in face-to-face interventions in Clinical Psychology, the 
ability to establish rapport, engage, empathize, and demonstrate good interview skills are well 
recognised as powerful determinants of outcome. A recent review by Johns, Barkham, 
Kellett, & Saxon (2019) reported that 5% of the variance in patient outcomes is accounted for 
by the variability between therapists.  Although a 5% effect may appear small relative to 
patient variability, some studies in the review reported some therapists being consistently 
more than twice as effective as others. Therapist characteristics thus make a crucial 
contribution to variability in outcomes. Similar variability in how health behaviour change 
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interventions are delivered and by whom, is also likely to be a powerful determinant of 
variability in outcomes.   
Facts versus Feelings 
Affect plays a key role in influencing self-regulatory behaviour (Williams, Rhodes and 
Connor 2019). In the following section, following Williams et al. (2019) affect is defined as 
including core affect (e.g. hedonic response [pleasure/displeasure] and arousal), emotions 
(e.g. anger, fear, sorrow, joy), and moods (e.g. happy, contented, depressed, irritable).  It is 
well recognised, for example, that depression can have a major impact on outcomes in long-
term conditions by reducing medication adherence (Grenard, Munjas, Adams, Suttorp, 
Maglione, McGlynn & Gellad (2011). Given that a very high proportion of people with 
chronic health problems suffer from co-morbid depression, depression is likely to also 
significantly reduce the effectiveness of self-regulation interventions. There does not appear 
to have been a sufficient focus on the role of emotion. In their meta-review of meta-analyses 
of self-regulation interventions and adherence, Wilson et al. (2019) concluded: “it has been 
posited that emotion regulation (e.g., successfully reducing negative emotions in the context 
of stress) may be important for managing goal-directed behavior. However, the included 
meta-analyses did not provide sufficient information to assess adherence interventions 
designed to promote emotion regulation”.  Leventhal’s Common-Sense Model or CSM 
(Leventhal, Brissette, & Leventhal, 2003) is a very influential theory of self-regulation which 
has been widely used to inform intervention development. The CSM is explicitly a dual-
process model, with cognitive representations (illness perceptions) running in parallel with 
emotional representations (anxiety/worry/depression) and both influencing each other. 
Interventions based on the CSM tend to focus on the former by eliciting and modifying 
illness perceptions (e.g., timeline, consequence, timeline, control) in an attempt to change 
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behaviour and improve outcomes, e.g. Petrie, Cameron, Ellis, Buick, & Weinman (2002). 
Such approaches focus mainly on eliciting and challenging cognitions and it is assumed that 
distress reduces as a consequence. We need to pay more attention to the role that emotions 
play in directly regulating our health behaviour, rather than seeing affect as a secondary 
outcome to be improved by changing illness perceptions. It is also important to highlight that 
some health behaviours and some health risk behaviours are used as emotion regulation 
strategies. For example, a person might use physical activity to feel happier, whereas another 
person might resort to eating chocolate to achieve the same outcome. 
As Williams et al. (2019) point out, it is only recently that affective factors in their own right 
have become a major focus for health behaviour science and interventions. For many of us, 
our health decisions are often guided by emotion. For example, many people do not take part 
in cancer screening when they “know” they should. Many people also do not register as 
posthumous organ donors (despite “knowing” they should), for a variety of reasons, 
including a superstitious belief that registration may, in some way, hasten their own death. 
Such individuals are often perfectly aware that these beliefs do not make any sense – but the 
emotional discomfort (or attempts to avoid these unpleasant feelings) is a critical determinant 
of behaviour1. Moving forward, we need to focus more on the key role that emotions play in 
influencing our self-regulatory behaviour. We need to investigate if and how these emotional 
barriers can be better understood and overcome in order to improve health outcomes. 
 
                                                 
I have significantly delayed presenting to accident and emergency services on two occasions. The first was a 
24-hour delay presenting with severe chest pain which turned out to be a blocked bile duct. The second was a 
3-week delay in presenting with a broken leg. In subsequent attempts to try and understand my clearly 
irrational behaviour, I came to the conclusion that emotion was the main reason for my delay i.e., fear of 
embarrassment. I did not want to attend the emergency services in case I was told that: (a) I had indigestion 
and (b) a sprained ankle. 
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Conclusion – Things can only get better… 
My comments have focused on three main areas, effect size, form of delivery and the role of 
emotion. The special edition has highlighted a number of important limitations in how self-
regulation research and evidence syntheses are conducted and reported. Hennessey et al. 
(2019) conclude that progress over the last 20 years has been modest. However, as I have 
argued above, small treatment effect sizes can lead to very important outcomes at the 
population level. Furthermore, I believe that there is room for optimism as our behaviours as 
researchers should be amenable to change. Take the example of replication. Psychology in 
general has recently admitted a “replication crisis” and is taking steps to improve the 
situation. The Many Labs 2 initiative (https://osf.io/8cd4r/) is conducting pre-registered 
replications of many classic and contemporary published findings with protocols that were 
peer reviewed in advance in order to examine variation in effect magnitudes across sample 
and settings. Such initiatives should improve the confidence we can have in replicated 
studies. Another area which is improving is the reporting of methodological details, 
particularly defining intervention content more precisely. Journals now often provide the 
option of on-line supplementary files, where full details of intervention protocols can be 
made available to readers. Similarly, these is also an increase in the availability of treatment 
manuals from intervention studies. Developments in the use of established classification 
systems, e.g., taxonomies of BCTs (e.g., Michie et al., 2013), have led to tighter definitions 
and detailing of specific BCTs that have been used in interventions. Taken together, these 
should help us achieve greater clarity of exactly what was delivered in an intervention and 
how it was delivered and by whom. This will enable us to better evaluate the relative 
importance of different forms of delivery. Furthermore, developments such as the new 
Theory & Technique Tool  https://theoryandtechniquetool.humanbehaviourchange.org/, an 
online resource which provides information about links between BCTs and their mechanisms 
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of actions will hopefully help in the development and evaluation of theory-based self-
regulation interventions. 
This special edition also highlight the relatively low ratings of many reviews on the 
AMSTAR or AMSTAR 2 critical appraisal tool for systematic reviews. Greater awareness 
(e.g., as a direct result of this special edition of Health Psychology Review) should result in 
significant improvements in the conducting and reporting of future reviews in this area. The 
special issue has also called for a greater focus on the role of emotion-regulation in self-
regulation interventions and I believe this will lead to a significant improvement in the 
effectiveness of our self-regulation interventions. I am also confident that in the future, we 
will learn more about not only if self-regulatory interventions work, but how they work. As 
Wilson et al. (2019) highlight, this area will benefit hugely from more tests of mediation to 
specify and test the putative causal pathways linking self-regulation interventions to 
behavioural outcomes. Such evidence will then enable us to identify the best variables to 
target in interventions to bring about health behaviour change. To conclude, the limitations 
highlighted in this special issue will hopefully stimulate an improvement in our science and 
our reporting methods so that in future, self-regulatory interventions will lead to more 
effective health behaviour change. 
 
References 
Anvari, F., & Lakens, D. (2019). Using anchor-based methods to determine the smallest 
effect size of interest. Preprint on PsyArXiv. 
 Cuijpers, P., van Straten, A., Bohlmeijer, E., Hollon, S. D., & Andersson, G. (2009). The 
effects of psychotherapy for adult depression are overestimated: a meta-analysis of study 
 10 
quality and effect size. Psychological Medicine, 40(2), 211. doi: 
10.1017/S0033291709006114  
Dombrowski, S. U., O'Carroll, R., & Williams, B. (2016). Form of delivery as a key “active 
ingredient” in behaviour change interventions. British Journal of Health Psychology, 21(4), 
733–740. doi:10.1111/bjhp.12203 
Grenard, J. L., Munjas, B. A., Adams, J. L., Suttorp, M., Maglione, M., McGlynn, E. A., & 
Gellad, W. F. (2011). Depression and Medication Adherence in the Treatment of Chronic 
Diseases in the United States: A Meta-Analysis. J Gen Intern Med, 26(10), 1175–1182. 
http://doi.org/10.1007/s11606-011-1704-y 
 
Hennessy, E. A., Johnson, B. T., Acabchuk, R. L., McCloskey, K., & Stewart-James, J. 
(2019). Self-Regulation Mechanisms in Health Behaviour Change: A Systematic Meta-
Review of Meta-Analyses, 2006-2017. Health Psychology Review, 
doi:10.1080/17437199.2019.1679654 
Johns, R. G., Barkham, M., Kellett, S., & Saxon, D. (2019). A systematic review of therapist 
effects: A critical narrative update and refinement to review. Clinical Psychology Review, 67, 
78–93. doi:10.1016/j.cpr.2018.08.004 
Leucht, S., Hierl, S., Kissling, W., Dold, M., & Davis, J. M. (2012). Putting the efficacy of 
psychiatric and general medicine medication into perspective: review of meta-analyses. 
British Journal of Psychiatry, 200(2), 97–106. doi:10.1192/bjp.bp.111.096594  
Leventhal, H., Brissette, I., & Leventhal, E. A. (2003). The common-sense model of self-
regulation of health and illness. In L. Cameron & H. Leventhal (Eds.), The Self-Regulation of 
Health and Illness Behaviour (pp.  42-65). London: Routledge. 
 11 
Many Labs 2: Investigating Variation in Replicability Across Sample and Setting 
 https://osf.io/8cd4r/ 
Michie, S., Richardson, M., Johnston, M., Abraham, C., Francis, J., Hardeman, W., et al. 
(2013). The Behavior Change Technique Taxonomy (v1) of 93 Hierarchically Clustered 
Techniques: Building an International Consensus for the Reporting of Behavior Change 
Interventions. Annals of Behavioral Medicine, 46(1), 81–95. doi:10.1007/s12160-013-9486-6 
NNT website. Quick summaries of evidence-based medicine. https://www.thennt.com/  
O'Carroll, R. E. (2013). Health Psychology interventions. British Journal of Health 
Psychology, 19(2), 235–239. doi:10.1111/bjhp.12082 
Ogden, J. (2016). Do no harm: Balancing the costs and benefits of patient outcomes in Health 
Psychology research and practice. Journal of Health Psychology, 24(1), 25–37. 
doi:10.1177/1359105316648760  
Petrie, K. J., Cameron, L. D., Ellis, C. J., Buick, D., & Weinman, J. (2002). Changing illness 
perceptions after myocardial infarction: an early intervention randomized controlled trial. 
Psychosomatic Medicine, 64(4), 580–586. doi:10.1097/00006842-200207000-00007 
Steptoe, A. (2019) Revisiting public health psychology. European Health Psychologist, 21(1), 
586-587. 
Theory & Technique Tool  https://theoryandtechniquetool.humanbehaviourchange.org/ 
 
Trewby, P. N., Reddy, A. V., Trewby, C. S., Ashton, V. J., Brennan, G., & Inglis, J. (2002). 
Are preventive drugs preventive enough? A study of patients' expectation of benefit from 
preventive drugs. Clinical Medicine, 2(6), 527–533. 
 12 
 
Williams, D. M., Rhodes, R. E., & Conner, M. T. (2019). Conceptualizing and intervening on 
affective determinants of health behaviour. Psychology and Health, 34(11), 1267–1281. 
doi:10.1080/08870446.2019.1675659 
 
Wilson, T. E., Hennessy, E. A., Falzon, L., Boyd, R., Kronish, I. M., & Birk, J. L. (2019). 
Effectiveness of interventions targeting self-regulation to improve adherence to chronic 
disease medications: A meta-review of meta-analyses. Health Psychology Review. 
 
